De Novo Mutations in FOXP1 in Cases with Intellectual Disability, Autism, and Language Impairment
Fadi F. Hamdan(Centre Hospitalier Universitaire Sainte-Justine), Jacques L. Michaud(Centre Hospitalier Universitaire Sainte-Justine), Éric Fombonne(Oregon Health & Science University), Mathieu Langlois(Montreal Heart Institute), Miriam H. Beauchamp(Université de Montréal), Hussein Daoud(Université de Montréal), Amélie Piton(Centre National de la Recherche Scientifique), Laurent Mottron(Centres Intégré Universitaires de Santé et de Services Sociaux), Sylvia Dobrzeniecka(Centre Hospitalier de l’Université de Montréal), Jean‐Claude Lacaille(Université de Montréal), Gila Foomani(Montreal Children's Hospital), Pierre Drapeau(Université de Montréal), Ridha Joober(McGill University), Ronald G. Lafrenière(Xenon Pharmaceuticals (Canada)), Daniel Rochefort(Montreal Neurological Institute and Hospital), Michael Phillips(The University of Western Australia), Marie‐Odile Krebs(Inserm), Julie Gauthier(Centre Hospitalier Universitaire Sainte-Justine), Guy A. Rouleau(Montreal Neurological Institute and Hospital)
Cited by 243
Related Papers
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
|Neuron|2015|1.5k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments
|PLoS Genetics|2014|672
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
|Nature|1988|670
Burnout in medical students before residency: A systematic review and meta-analysis
|European Psychiatry|2018|588